< Back to scientific publications

Magazine 4.3

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Authors: Pellicelli A et al

Date: May 20

Scope of interest: infectious/hepatological




You may also be interested in:

Magazine 2.12

“Hypothesis of COVID-19 Therapy with sildenafil”

Authors: Limodio M. et al.

Date: 2020

Scope of interest: infectivology


Read details
Magazine 4.26

The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy

Authors: Morano A, Cerulli Irelli E, Fanella M, Zuliani L, Giallonardo AT, Di Bonaventura C.

Date: 2021

Scope of interest: Epilepsy/autoimmune diseases of the CNS


Read details
Magazine 2.07

Platelet activation by riboflavin and UV light: is it really the other side of the coin?

Authors: Del Proposto G., Lanti A., Fiorelli E., Palazzo G., Guiducci G., Messina F., De Masi A., Ferraro A.S., Chiru O.M., Cerrone .P, Antonelli M., Adorno G.

Date: 2014

Scope of interest: Haematology


Read details